Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,873
  • Shares Outstanding, K 8,669
  • Annual Sales, $ 86,950 K
  • Annual Income, $ -172,420 K
  • 60-Month Beta 2.09
  • Price/Sales 0.23
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TXMD with:

Options Overview Details

View History
  • Implied Volatility 354.69% ( +354.69%)
  • Historical Volatility 190.10%
  • IV Percentile 85%
  • IV Rank 43.09%
  • IV High 748.60% on 03/15/22
  • IV Low 56.46% on 07/09/21
  • Put/Call Vol Ratio 0.53
  • Today's Volume 465
  • Volume Avg (30-Day) 153
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 43,257
  • Open Int (30-Day) 40,344

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -3.04
  • Number of Estimates 1
  • High Estimate -3.04
  • Low Estimate -3.04
  • Prior Year -5.50
  • Growth Rate Est. (year over year) +44.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.21 +15.84%
on 05/19/22
11.99 -78.65%
on 04/26/22
-8.57 (-77.00%)
since 04/22/22
3-Month
2.21 +15.84%
on 05/19/22
23.00 -88.87%
on 03/23/22
-8.05 (-75.87%)
since 02/23/22
52-Week
2.21 +15.84%
on 05/19/22
69.50 -96.32%
on 06/09/21
-58.94 (-95.84%)
since 05/21/21

Most Recent Stories

More News
TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced the FDA’s approval of a supplemental New Drug Application (sNDA)...

TXMD : 2.56 (-17.42%)
TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript

TXMD earnings call for the period ending March 31, 2022.

TXMD : 2.56 (-17.42%)
TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 2.56 (-17.42%)
CHGCY : 14.0200 (+2.00%)
TherapeuticsMD Announces First Quarter 2022 Financial Results

TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the first quarter ended March 31, 2022.

TXMD : 2.56 (-17.42%)
Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Misses Revenue Estimates

Harpoon Therapeutics, Inc. (HARP) delivered earnings and revenue surprises of -29.17% and 47.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

HARP : 2.14 (-16.08%)
TXMD : 2.56 (-17.42%)
TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced that it will report its first quarter 2022 financial results...

TXMD : 2.56 (-17.42%)
TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women’s healthcare company, announced today the closing of the divestiture of vitaCare Prescription Services...

TXMD : 2.56 (-17.42%)
GDRX : 8.22 (+3.14%)
TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript

TXMD earnings call for the period ending December 31, 2021.

TXMD : 2.56 (-17.42%)
TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -50% and 37.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 2.56 (-17.42%)
MRNS : 5.47 (+2.82%)
Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of 2.47% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

NKTR : 3.57 (-7.99%)
TXMD : 2.56 (-17.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 3.46
2nd Resistance Point 3.26
1st Resistance Point 2.91
Last Price 2.56
1st Support Level 2.36
2nd Support Level 2.15
3rd Support Level 1.80

See More

52-Week High 69.50
Fibonacci 61.8% 43.80
Fibonacci 50% 35.85
Fibonacci 38.2% 27.91
Last Price 2.56
52-Week Low 2.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar